Which Is First Argon Laser Therapy Or Intravitreal Bivacizumab In Branch Retinal Vein Occlusion With Macular Oedema.

Not Applicable

• Conditions: Eye Diseases; Macular edema, branch retinal vein occlusion

• Registration Number: PACTR201705002168252
• Lead Sponsor: Ophthalmology department

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-04-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients with macular edema secondary to branch retinal vein occlusion

Exclusion Criteria

The patients who had coexisting retinal disease (like diabetic retinopathy and epiretinal membrane); media opacities that could decrease visual acuity, or macular ischemia, concurrent ocular in¿ammation or infection, intraocular surgery (including post vitrectomized eyes) within the previous 3 months, patients of incomplete follow up

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Best corrected visual effect

Secondary Outcome Measures

Name	Time	Method
central foveal thickness